RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

SRS Capital Advisors, Inc.'s Holding History (CIK: 0001586767)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 8,316 Value ($000) $26 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 6,603 Value ($000) $32 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 3,620 Value ($000) $18 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 1,400 Value ($000) $7 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 280 Value ($000) $2 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 29 Value ($000) $0 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 355 Value ($000) $3 Avg Close $8.72 Range $6.75 - $10.66